Fibril-forming motifs are essential and sufficient for the fibrillization of human Tau

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Meng, Sheng Rong ^a   Zhu, Ying Zhu ^a   Guo, Tong ^a   Liu, Xiao Ling ^a   Chen, Jie ^a   Liang, Yi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; PRION PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT TAU PROTEIN[244-372]; TAU PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG; AMYLOID; PRIMER DNA; THIAZOLE DERIVATIVE;

AMINO ACID SEQUENCE; ARTICLE; CIRCULAR DICHROISM; DEGENERATIVE DISEASE; FIBRILLIZATION; GENE DELETION; HUMAN; KINETICS; MACROMOLECULE; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY; BIOSYNTHESIS; GENETICS; METABOLISM; PLASMID;

AMINO ACID MOTIFS; AMYLOID; CIRCULAR DICHROISM; DNA PRIMERS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; PLASMIDS; PROTEIN FOLDING; RECOMBINANT PROTEINS; TAU PROTEINS; THIAZOLES;

EID: 84862231306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038903     Document Type: Article

References (50)

1. Dobson CM, (2003) Protein folding and misfolding. Nature 426: 884-890.
2. Prusiner SB, (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
3. Goedert M, (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16: 460-465.
4. Guest WC, Silverman JM, Pokrishevsky E, O'Neill MA, Grad LI, et al. (2011) Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. J Toxicol Env Heal A 74: 1433-1459.
5. Soto C, (2011) Prion hypothesis: the end of the controversy? Trends Biochem Sci. 36: 151-158.
6. Breydo L, Wu JW, Uversky VN, (2012) α-Synuclein misfolding and Parkinson's disease. Biochim Biophys Acta 1822: 261-285.
7. Blanco LP, Evans ML, Daniel R. Smith DR, Badtke MP, et al. (2012) Diversity, biogenesis and function of microbial amyloids. Trends Microbiol 20: 66-73.
8. Wang X, Zhou Y, Ren JJ, Hammer ND, Chapman MR, (2010) Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci USA 107: 163-168.
9. Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, et al. (2006) Functional amyloid formation within mammalian tissue. PLoS Biol 4: e6.
10. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, et al. (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325: 328-332.
11. Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, et al. (1994) Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265: 1464-1467.
12. Mo ZY, Zhu YZ, Zhu HL, Fan JB, Chen J, et al. (2009) Low micromolar zinc accelerates the fibrillization of human Tau via bridging of Cys-291 and Cys-322. J Biol Chem 284: 34648-34657.
13. Ballatore C, Lee VM, Trojanowski JQ, (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8: 663-672.
14. Zhou Z, Fan JB, Zhu HL, Shewmaker F, Yan X, et al. (2009) Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding. J Biol Chem 284: 30148-30158.
15. Miyata T, Oda O, Inagi R, Iida Y, Araki N, et al. (1993) β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92: 1243-1252.
16. Kong FL, Cheng W, Chen J, Liang Y, (2011) D-ribose glycates β2-microglobulin to form aggregates with high cytotoxicity through a ROS-mediated pathway. Chem-Biol Interact 194: 69-78.
17. Zhou Z, Yan X, Pan K, Chen J, Xie ZS, et al. (2011) Fibril formation of the rabbit/human/bovine prion proteins. Biophys J 101: 1483-1492.
18. Rossetti G, Cong X, Caliandro R, Legname G, Carloni P, (2011) Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases. J Mol Biol 411: 700-712.
19. Anfinsen CB, (1973) Principles that govern the folding of protein chains. Science 181: 223-230.
20. Zhu HL, Fernandez C, Fan JB, Shewmaker F, Chen J, et al. (2010) Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated Tau filament formation. J Biol Chem 285: 3592-3599.
21. Zhu HL, Meng SR, Fan JB, Chen J, Liang Y, (2011) Fibrillization of human Tau is accelerated by exposure to lead via interaction with His-330 and His-362. PLoS One 6: e25020.
22. von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, et al. (2000) Assembly of Tau protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure. Proc Natl Acad Sci USA 97: 5129-5134.
23. Li W, Lee VM, (2006) Characterization of two VQIXXK motifs for tau fibrillization in vitro. Biochemistry 45: 15692-15701.
24. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, et al. (2002) A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99: 16742-16747.
25. Williams AD, Portelius E, Kheterpal I, Guo JT, Cook KD, et al. (2004) Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis. J Mol Biol 335: 833-842.
26. Tjernberg LO, Callaway DJ, Tjernberg A, Hahne S, Lilliehook C, et al. (1999) A molecular model of Alzheimer amyloid β-peptide fibril formation. J Biol Chem 274: 12619-12625.
27. Ivanova MI, Thompson MJ, Eisenberg D, (2006) A systematic screen of β2-microglobulin and insulin for amyloid-like segments. Proc Natl Acad Sci USA 103: 4079-4082.
28. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, et al. (2005) Structure of the cross-β spine of amyloid-like fibrils. Nature 435: 773-778.
29. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. (2007) Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature. Nature 447: 453-457.
30. Garbuzynskiy SO, Lobanov MY, Galzitskaya OV, (2010) FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics 26: 326-332.
31. Zhang Z, Chen H, Lai L, (2007) Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 23: 2218-2225.
32. Lopez de la Paz M, Serrano L, (2004) Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA 101: 87-92.
33. Kallberg Y, Gustafsson M, Persson B, Thyberg J, Johansson J, (2001) Prediction of amyloid fibril-forming proteins. J Biol Chem 276: 12945-12950.
34. Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, et al. (2006) The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci USA 103: 4074-4078.
35. Goldschmidt L, Teng PK, Riek R, Eisenberg D, (2010) Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA 107: 3487-3492.
36. Alberti S, Halfmann R, King O, Kapila A, Lindquist S, (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137: 146-158.
37. Mandelkow E, Song YH, Schweers O, Marx A, Mandelkow EM, (1995) On the structure of microtubules, tau, and paired helical filaments. Neurobiol Aging 16: 347-354.
38. Kosik KS, Joachim CL, Selkoe DJ, (1986) Microtubule-associated protein Tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83: 4044-4048.
39. Kuret J, Chirita CN, Congdon EE, Kannanayakal T, Li G, et al. (2005) Pathways of Tau fibrillization. Biochim Biophys Acta 1739: 167-178.
40. Bibow S, Mukrasch MD, Chinnathambi S, Biernat J, Griesinger C, et al. (2011) The dynamic structure of filamentous Tau. Angew Chem Int Ed 50: 11520-11524.
41. von Bergen M, Barghorn S, Li L, Marx A, Biernat J, et al. (2001) Mutations of Tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure. J Biol Chem 276: 48165-48174.
42. Teng PK, Eisenberg D, (2009) Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng Des Sel 22: 531-536.
43. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, et al. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90: 549-558.
44. Colby DW, Cassady JP, Lin GC, Ingram VM, Wittrup KD, (2006) Stochastic kinetics of intracellular huntingtin aggregate formation. Nat Chem Biol 2: 319-323.
45. Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, et al. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307: 262-265.
46. Makarava N, Baskakov IV, (2008) The same primary structure of the prion protein yields two distinct self-propagating states. J Biol Chem 283: 15988-15996.
47. Ivanova MI, Sievers SA, Sawaya MR, Wall JS, Eisenberg D, (2009) Molecular basis for insulin fibril assembly. Proc Natl Acad Sci USA 106: 18990-18995.
48. Sievers SA, Karanicolas J, Chang HW, Zhao A, Jiang L, et al. (2011) Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475: 96-100.
49. Landau M, Sawaya MR, Faull KF, Laganowsky A, Jiang L, et al. (2011) Towards a pharmacophore for amyloid. PLoS Biol 9: e1001080.
50. Men D, Guo YC, Zhang ZP, Wei HP, Zhou YF, et al. (2009) Seeding-induced self-assembling protein nanowires dramatically increase the sensitivity of immunoassays. Nano Lett 9: 2246-2250.